IL-2/Anti-IL-2 antibody complex treatment inhibits the development but not the progression of herpetic stromal keratitis

Journal of Immunology

Volumn 194, Issue 1, 2015, Pages 273-282

  Gaddipati, Subhash ^a,b   Estrada, Kathleen ^a,c   Rao, Pushpa ^a,b   Jerome, Andrew David ^a,b   Suvas, Susmit ^a,b  

^a OAKLAND UNIVERSITY   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 ANTIBODY; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, MOUSE; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL TRANSPORT; CORNEA OPACITY; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; GRANULOCYTE; HERPES SIMPLEX VIRUS 1; HERPETIC STROMAL KERATITIS; IMMUNE RESPONSE; INNATE IMMUNITY; KERATITIS; LYMPHOCYTE DIFFERENTIATION; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; VIRUS LOAD; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL MOTION; CORNEA; CYTOLOGY; DISEASE COURSE; IMMUNOLOGY; IMMUNOTHERAPY; KERATITIS, HERPETIC; LYMPH NODE; PATHOLOGY; REGULATORY T LYMPHOCYTE; SECRETION (PROCESS); SPLEEN; TH1 CELL; VIROLOGY;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL MOVEMENT; CORNEA; DISEASE PROGRESSION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRANULOCYTES; HERPESVIRUS 1, HUMAN; IMMUNOTHERAPY; INTERFERON-GAMMA; INTERLEUKIN-2; KERATITIS, HERPETIC; LYMPH NODES; MICE; MICE, INBRED C57BL; SPLEEN; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; VIRAL LOAD;

EID: 84919683343     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401285     Document Type: Article

References (49)

1. Thomas, J., S. Gangappa, S. Kanangat, and B. T. Rouse. 1997. On the essential involvement of neutrophils in the immunopathologic disease: Herpetic stromal keratitis. J. Immunol. 158: 1383-1391.
2. Niemialtowski, M. G., and B. T. Rouse. 1992. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J. Immunol. 149: 3035-3039.
3. Rowe, A. M., A. J. St Leger, S. Jeon, D. K. Dhaliwal, J. E. Knickelbein, and R. L. Hendricks. 2013. Herpes keratitis. Prog. Retin. Eye Res. 32: 88-101.
4. Inoue, Y. 2008. Immunological aspects of herpetic stromal keratitis. Semin. Ophthalmol. 23: 221-227.
5. Frank, G. M., K. A. Buela, D. M. Maker, S. A. Harvey, and R. L. Hendricks. 2012. Early responding dendritic cells direct the local NK response to control herpes simplex virus 1 infection within the cornea. J. Immunol. 188: 1350-1359.
6. Conrady, C. D., M. Zheng, N. A. Mandal, N. van Rooijen, and D. J. Carr. 2013. IFN-A-driven CCL2 production recruits inflammatory monocytes to infection site in mice. Mucosal Immunol. 6: 45-55.
7. Conrady, C. D., M. Zheng, D. U. Stone, and D. J. Carr. 2012. CD8+ T cells suppress viral replication in the cornea but contribute to VEGF-C-induced lymphatic vessel genesis. J. Immunol. 189: 425-432.
8. Suvas, S., A. K. Azkur, B. S. Kim, U. Kumaraguru, and B. T. Rouse. 2004. CD4+ CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J. Immunol. 172: 4123-4132.
9. Sehrawat, S., S. Suvas, P. P. Sarangi, A. Suryawanshi, and B. T. Rouse. 2008. In vitro-generated antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells control the severity of herpes simplex virus-induced ocular immunoinflammatory lesions. J. Virol. 82: 6838-6851.
10. Veiga-Parga, T., A. Suryawanshi, and B. T. Rouse. 2011. Controlling viral immuno-inflammatory lesions by modulating aryl hydrocarbon receptor signaling. PLoS Pathog. 7: E1002427.
11. Nesburn, A. B., I. Bettahi, G. Dasgupta, A. A. Chentoufi, X. Zhang, S. You, N. Morishige, A. J. Wahlert, D. J. Brown, J. V. Jester, et al. 2007. Functional Foxp3+ CD4+ CD25(Bright+) "natural" regulatory T cells are abundant in rabbit conjunctiva and suppress virus-specific CD4+ and CD8+ effector T cells during ocular herpes infection. J. Virol. 81: 7647-7661.
12. Webster, K. E., S. Walters, R. E. Kohler, T. Mrkvan, O. Boyman, C. D. Surh, S. T. Grey, and J. Sprent. 2009. In vivo expansion of T reg cells with IL-2-mAb complexes: Induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression. J. Exp. Med. 206: 751-760.
13. Dinh, T. N., T. S. Kyaw, P. Kanellakis, K. To, P. Tipping, B. H. Toh, A. Bobik, and A. Agrotis. 2012. Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis. Circulation 126: 1256-1266.
14. Wang, Y. M., and S. I. Alexander. 2013. IL-2/anti-IL-2 complex: A novel strategy of in vivo regulatory T cell expansion in renal injury. J. Am. Soc. Nephrol. 24: 1503-1504.
15. Wilson, M. S., J. T. Pesce, T. R. Ramalingam, R. W. Thompson, A. Cheever, and T. A. Wynn. 2008. Suppression of murine allergic airway disease by IL-2: Anti- IL-2 monoclonal antibody-induced regulatory T cells. J. Immunol. 181: 6942-6954.
16. Banerjee, K., P. S. Biswas, B. Kim, S. Lee, and B. T. Rouse. 2004. CXCR22/2 mice show enhanced susceptibility to herpetic stromal keratitis: A role for IL-6- induced neovascularization. J. Immunol. 172: 1237-1245.
17. Zheng, M., M. A. Schwarz, S. Lee, U. Kumaraguru, and B. T. Rouse. 2001. Control of stromal keratitis by inhibition of neovascularization. Am. J. Pathol. 159: 1021-1029.
18. Morrison, B. E., S. J. Park, J. M. Mooney, and B. Mehrad. 2003. Chemokinemediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J. Clin. Invest. 112: 1862-1870.
19. Kim, B., P. P. Sarangi, Y. Lee, S. Deshpande Kaistha, S. Lee, and B. T. Rouse. 2006. Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation. J. Leukoc. Biol. 80: 1405-1415.
20. Lee, S. K., B. K. Choi, W. J. Kang, Y. H. Kim, H. Y. Park, K. H. Kim, and B. S. Kwon. 2008. MCP-1 derived from stromal keratocyte induces corneal infiltration of CD4+ T cells in herpetic stromal keratitis. Mol. Cells 26: 67-73.
21. Keadle, T. L., J. L. Morris, J. S. Pepose, and P. M. Stuart. 2002. CD4+ and CD8+ cells are key participants in the development of recurrent herpetic stromal keratitis in mice. Microb. Pathog. 32: 255-262.
22. Xu, D., H. Liu, M. Komai-Koma, C. Campbell, C. McSharry, J. Alexander, and F. Y. Liew. 2003. CD4+CD25+ regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J. Immunol. 170: 394-399.
23. Taylor, J. J., M. Mohrs, and E. J. Pearce. 2006. Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J. Immunol. 176: 5839-5847.
24. Shen, E., K. Zhao, C. Wu, and B. Yang. 2011. The suppressive effect of CD25+ Treg cells on Th1 differentiation requires cell-cell contact partially via TGF-b production. Cell Biol. Int. 35: 705-712.
25. Belkaid, Y., and B. T. Rouse. 2005. Natural regulatory T cells in infectious disease. Nat. Immunol. 6: 353-360.
26. Rubtsov, Y. P., J. P. Rasmussen, E. Y. Chi, J. Fontenot, L. Castelli, X. Ye, P. Treuting, L. Siewe, A. Roers, W. R. Henderson, Jr., et al. 2008. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28: 546-558.
27. Schreiber, T. H., D. Wolf, M. S. Tsai, J. Chirinos, V. V. Deyev, L. Gonzalez, T. R. Malek, R. B. Levy, and E. R. Podack. 2010. Therapeutic Treg expansion in mice by TNFRSF25 prevents allergic lung inflammation. J. Clin. Invest. 120: 3629-3640.
28. J Reddy, P. B., T. H. Schreiber, N. K. Rajasagi, A. Suryawanshi, S. Mulik, T. Veiga-Parga, T. Niki, M. Hirashima, E. R. Podack, and B. T. Rouse. 2012. TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions. J. Virol. 86: 10606-10620.
29. Screaton, G. R., X. N. Xu, A. L. Olsen, A. E. Cowper, R. Tan, A. J. McMichael, and J. I. Bell. 1997. LARD: A new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. Proc. Natl. Acad. Sci. USA 94: 4615-4619.
30. Shevach, E. M. 2012. Application of IL-2 therapy to target T regulatory cell function. Trends Immunol. 33: 626-632.
31. Lund, J. M., L. Hsing, T. T. Pham, and A. Y. Rudensky. 2008. Coordination of early protective immunity to viral infection by regulatory T cells. Science 320: 1220-1224.
32. Conrady, C. D., H. Jones, M. Zheng, and D. J. Carr. 2011. A functional type I interferon pathway drives resistance to cornea herpes simplex virus type 1 infection by recruitment of leukocytes. J. Biomed. Res. 25: 111-119.
33. Martinez, J., X. Huang, and Y. Yang. 2008. Direct action of type I IFN on NK cells is required for their activation in response to vaccinia viral infection in vivo. J. Immunol. 180: 1592-1597.
34. Knorr, M., T. Munzel, and P. Wenzel. 2014. Interplay of NK cells and monocytes in vascular inflammation and myocardial infarction. Front. Physiol. 5: 295.
35. Suryawanshi, A., T. Veiga-Parga, N. K. Rajasagi, P. B. Reddy, S. Sehrawat, S. Sharma, and B. T. Rouse. 2011. Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology. J. Immunol. 187: 1919-1930.
36. Tumpey, T. M., H. Cheng, D. N. Cook, O. Smithies, J. E. Oakes, and R. N. Lausch. 1998. Absence of macrophage inflammatory protein-1a prevents the development of blinding herpes stromal keratitis. J. Virol. 72: 3705-3710.
37. Tadokoro, C. E., G. Shakhar, S. Shen, Y. Ding, A. C. Lino, A. Maraver, J. J. Lafaille, and M. L. Dustin. 2006. Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo. J. Exp. Med. 203: 505-511.
38. Tang, Q., J. Y. Adams, A. J. Tooley, M. Bi, B. T. Fife, P. Serra, P. Santamaria, R. M. Locksley, M. F. Krummel, and J. A. Bluestone. 2006. Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol. 7: 83-92.
39. Shafiani, S., G. Tucker-Heard, A. Kariyone, K. Takatsu, and K. B. Urdahl. 2010. Pathogen-specific regulatory T cells delay the arrival of effector T cells in the lung during early tuberculosis. J. Exp. Med. 207: 1409-1420.
40. Samy, E. T., L. A. Parker, C. P. Sharp, and K. S. Tung. 2005. Continuous control of autoimmune disease by antigen-dependent polyclonal CD4+CD25+ regulatory T cells in the regional lymph node. J. Exp. Med. 202: 771-781.
41. Uhlig, H. H., J. Coombes, C. Mottet, A. Izcue, C. Thompson, A. Fanger, A. Tannapfel, J. D. Fontenot, F. Ramsdell, and F. Powrie. 2006. Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis. J. Immunol. 177: 5852-5860.
42. Ring, S., S. C. Schäfer, K. Mahnke, H. A. Lehr, and A. H. Enk. 2006. CD4+ CD25+ regulatory T cells suppress contact hypersensitivity reactions by blocking influx of effector T cells into inflamed tissue. Eur. J. Immunol. 36: 2981-2992.
43. Kim, J. M., J. P. Rasmussen, and A. Y. Rudensky. 2007. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8: 191-197.
44. Chen, Z., A. E. Herman, M. Matos, D. Mathis, and C. Benoist. 2005. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J. Exp. Med. 202: 1387-1397.
45. Ding, Y., J. Xu, and J. S. Bromberg. 2012. Regulatory T cell migration during an immune response. Trends Immunol. 33: 174-180.
46. Koch, M. A., G. Tucker-Heard, N. R. Perdue, J. R. Killebrew, K. B. Urdahl, and D. J. Campbell. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10: 595-602.
47. Redjimi, N., C. Raffin, I. Raimbaud, P. Pignon, J. Matsuzaki, K. Odunsi, D. Valmori, and M. Ayyoub. 2012. CXCR3+ T regulatory cells selectively accumulate in human ovarian carcinomas to limit type I immunity. Cancer Res. 72: 4351-4360.
48. Zhou, X., S. L. Bailey-Bucktrout, L. T. Jeker, C. Penaranda, M. Martínez- Llordella, M. Ashby, M. Nakayama, W. Rosenthal, and J. A. Bluestone. 2009. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat. Immunol. 10: 1000-1007.
49. Korn, T., J. Reddy, W. Gao, E. Bettelli, A. Awasthi, T. R. Petersen, B. T. Bäckström, R. A. Sobel, K. W. Wucherpfennig, T. B. Strom, et al. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13: 423-431.